Neuromodulation and Cognitive Training in Opioid Use Disorder
NCT: NCT03773523 · ACTIVE_NOT_RECRUITING
Brief Summary
The relapsing nature of opioid use disorder is a major obstacle to successful treatment. About 90% of those entering treatment will relapse within one year. To improve treatment outcome, new interventions targeting the underlying brain biomarkers of relapse vulnerability hold significant promise in reducing this critical public health problem. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that can modulate brain connectivity.
Frequently Asked Questions
What is Neuromodulation and Cognitive Training in Opioid Use Disorder?
Neuromodulation and Cognitive Training in Opioid Use Disorder is a clinical trial registered under NCT03773523. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03773523?
The current status of NCT03773523 (Neuromodulation and Cognitive Training in Opioid Use Disorder) is: ACTIVE_NOT_RECRUITING.
When did Neuromodulation and Cognitive Training in Opioid Use Disorder start?
Neuromodulation and Cognitive Training in Opioid Use Disorder started on 2019-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.